12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Other News

Actelion cardiovascular, metabolic news

Shareholder Elliott Advisors (UK) Ltd. sent a letter to Actelion calling for the biotech's board to explore strategic alternatives, including the potential sale of the company, and for CEO Jean-Paul...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >